{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"Treating the Airways in COPD: Controlling the Dyspnea that Hinders Rehabilitation and Quality of Life - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"s2MpwfWy6s\"><a href=\"https:\/\/themedicalxchange.com\/en\/2012\/06\/25\/american-thoracic-society-ats-2012-international-c\/\">Treating the Airways in COPD:  Controlling the Dyspnea that Hinders Rehabilitation and Quality of Life<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2012\/06\/25\/american-thoracic-society-ats-2012-international-c\/embed\/#?secret=s2MpwfWy6s\" width=\"600\" height=\"338\" title=\"&#8220;Treating the Airways in COPD:  Controlling the Dyspnea that Hinders Rehabilitation and Quality of Life&#8221; &#8212; The Medical Xchange\" data-secret=\"s2MpwfWy6s\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2012\/06\/MXCR-2329_EN_Fig1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"San Francisco \u2013 Control of dyspnea, as part of a comprehensive management scheme in individuals with chronic obstructive pulmonary disease (COPD) has implications for prolonged survival. New data presented at the American Thoracic Society (ATS) 2012 International Conference has associated increased exercise capacity with a highly significant reduction in the risk of death over a follow-up exceeding 10 years. As a key factor in the ability to pursue exercise-related improvements in survival, control of dyspnea is among critical components in a management plan that serves as a paradigm shift designed to move from simple control of symptoms to protection against exacerbations and better long-term outcomes. Recent improvements in therapeutic options appear to be highly effective against dyspnea, which by increasing inspiratory capacity can be an important factor in attenuating the functional decline that increases the likelihood of exacerbations. This has provided the platform for redirecting the therapeutic goals in COPD from symptom control to improved survival. As an early domino in the cascade of events leading to exacerbations and end-stage disease, dyspnea is an important although not isolated target in the effort to improve COPD control."}